Boardroom Media Interview
ITL Health Group (ASX:ITD) is pleased to provide the opportunity to listen to an audio interview with Mr. Bill Mobbs, Executive Chairman.
The interview covers the recent sale of ITL’s Custom Pack business for $14.4m and the subsequent positive effects of the sale on strategy and expectations.
Click link below for full interview.
https://boardroom.media/broadcast/?eid=59e00cc2b0dc183b97586ab8
Enquires
ITL Health Group
Trevor Doolan
Company Secretary
T: +61 3 8773 3050
Media & Analysts
Walbrook IR
Ben Knowles
T: +61 0 426 277 760
E: ben.knowles@walbrookir.com.au
About ITL Health Group (ASX:ITD)
ITL Health Group is an innovative global medical technology company that creates and manufactures leading edge medical devices for the clinical, blood banking, and laboratory markets. ITL is a growing provider of specialist ancillary products for the blood culture testing market, estimated to be worth US$4.8bn by 2021.
ITL Health Group holds an IP portfolio of over 50 patents and sells into 55 countries, protecting healthcare workers in millions of procedures annually.
